Highly Sensitive Micellar Enhanced Spectrofluorimetric Method for Determination of Mirtazapine in Tablets and Human Urine: Application to In Vitro Drug Release and Content Uniformity Test

Table 5

Results of weight variation testing of MRZ tablets using the proposed method.

Parameter	Tablet number	Percentage of the label claim
Data	1	99.19 ± 1.51
	2	96.09 ± 1.21
	3	97.81 ± 2.26
	4	95.56 ± 0.89
	5	101.2 ± 2.32
	6	96.66 ± 1.32
	7	97.81 ± 0.84
	8	97.81 ± 0.96
	9	98.37 ± 1.05
	10	97.75 ± 0.77
Mean	97.83
SD	1.31
% RSD	1.34
Acceptance value (AV) [20]	3.81
Max. allowed AV (L1) [20]	15